This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- Original Article -
Effect of testosterone on morphine withdrawal syndrome in rats
Ali Reza Mohajjel Nayebi, Hassan Rezazadeh
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz 51664, Iran
Abstract
Aim: To determine whether testosterone is involved in morphine withdrawal syndrome (WS).
Methods: In order to induce dependency, rats were treated with subcutaneous injection of morphine (days 1_2, 5 mg/kg; days 3_5,
7.5 mg/kg; days 6_8, 10 mg/kg), and after the last dose of morphine (day 8) WS was induced by intraperitoneal
injection of naloxone (1 mg/kg). Wet dog shake (WDS), abdomen writhing (AW), and jumps (J) were recorded as
indicators of WS. Results: The severity of WDS, AW, and J in male rats was greater than that in females. Accordingly,
in 4-week castrated and flutamide-treated (10 mg/kg/day for 8 days, i.p.) male rats, WDS, AW, and J were
significantly decreased compared to male control rats. Testosterone replacement therapy (10 mg/kg/day for 8 days, i.m.) in
4-week castrated rats restored the severity of WDS, AW, and J behaviors to the level of non-castrated male rats,
whereas testosterone potentiated the WDS behavior in non-castrated male rats.
Conclusion: It can be concluded that testosterone might be effectively involved in morphine
WS. (Asian J Androl 2008 Sep; 10: 765_769)
Keywords: testosterone; castration; flutamide; morphine; withdrawal syndrome
Correspondence to: Dr Ali Reza Mohajjel Nayebi, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tabriz University
of Medical Sciences, Tabriz 51664, Iran.
Tel: +98-411-3341-315 Fax: +98-411-3344-798
E-mail: nayebia@yahoo.com
Received 2007-10-17 Accepted 2008-01-12
DOI: 10.1111/j.1745-7262.2008.00390.x
1 Introduction
Several studies have shown sex-related differences
in many pharmacological properties of morphine such
as antinociception [1_4], tolerance to analgesia [5], and
stimulant effects [6]. For most abused drugs, there has
been a long-standing "gender gap" in frequency of use
and addiction; that is, men are more likely than women
to use and become dependent on drugs [7]. Cicero
et al. [8] reported that severity of spontaneous morphine
withdrawal syndrome (WS) in male rats is greater than that
in female rats. These differences appear to reflect
intrinsic gender-related differences in the sensitivity of the
brain to morphine, as it has been shown that the levels of
morphine in blood and brain are similar in male and
female rats at comparable doses [2, 9].
It has been reported that the development of
tolerance and dependence on morphine can be inhibited by
concomitant chronic treatment with neurosteroids such as
allopregnanolone, pregnenolone sulfate, or progesterone
[10]. Furthermore, dependency on morphine markedly
decreases the brain concentrations of neurosteroids
pregnenolone, progesterone, pregnenolone sulfate, and
testosterone [11, 12], suggesting that changes in the
concentration of endogenous neurosteroids might be related
to the development of morphine dependence and
withdrawal. It has been shown that finastride, as a
5α-reductase inhibitor, could attenuate the development and
expression of naloxone-precipated WS [13]. According to
other studies, morphine-induced antinociception might
be altered by ovarioectomy, pregnancy, and/or exogenous
hormones [14, 15], whereas the effect of male gonadal
hormones on withdrawal syndrome has not been well studied. In the present study we showed that
testosterone plays an effective role in severity of
naloxone-precipitated WS of morphine.
2 Materials and methods
2.1 Ethics
Allprocedures were carried out under the ethical
guidelines of the Tabriz University of Medical Sciences (Tabriz,
Iran) and the studies received approval by the Ethics
Committee of the Tabriz University of Medical Sciences,
according to the guide for the care and use of laboratory
animals [National Institutes of Health (USA) Publication
No. 85-23, revised 1985].
2.2 Drugs
All drugs were prepared fresh on the days of experimentation. Testosterone enanthate (Darupakhsh,
Tehran, Iran) and flutamide (Sigma, Taufkirchen, Germany) were dissolved in sterile caster oil and
ethanol_water (2:1, v/v), respectively. Other drugs such as
morphine (Temad, Tehran, Iran) and naloxone (Darupakhsh) were dissolved in 0.9% saline. The
dosage of testosterone (10 mg/kg/day, i.p.) and flutamide
(10 mg/kg/day, i.m.) was prepared according to Nayebi
and Rezazadeh [16].
2.3 Animals
Male and female Wistar rats, weighing 225_250 g,
were obtained from the central animal house of the Tabriz
University of Medical Sciences. Animals were housed in
standard polypropylene cages, four per cage, under a 12
h:12 h light:dark schedule at an ambient temperature of
25 ± 2ºC and were allowed free food and water. Rats
were divided randomly into 13 experimental groups, each
comprising eight animals.
2.4 Surgical procedures
The male rats were fully anesthetized with
an i.p. injection of sodium pentobarbital (50 mg/kg).
Castration was carried out as follows: the ventral scrotum was
shaved and scrubbed with Betadine (Behvazan Co., Rasht,
Iran); a 1.5-cm transverse incision was made at midline
scrotum; the testes were exteriorized through the incision;
the tubules were tied with 0.4 silk suture; the testes,
epididymis, and associated fat pad were removed; and
the incision was closed with wound clips. A sham
operation was carried out by making the scrotal incision,
gently manipulating the testes, and closing the incision
with wound clips.
2.5 Behavioral study
In order to induce dependency, morphine was injected subcutaneously in a schedule of: days 1_2,
5 mg/kg; days 3_5, 7.5 mg/kg; and days 6_8, 10 mg/kg. Fifteen
minutes after the last dose of morphine (on day 8), WS
was induced by intraperitoneal injection of naloxone
(1 mg/kg). After 15 min, the numbers of wet dog shakes
(WDS), abdomen writhing (AW), and jumps (J) were recorded as indicators of WS for a period of 40 min by
an observer blind to treatment.
2.6 Expression of data and statistics
Descriptive statistics and comparisons of differences
between each data set were calculated using SigmaStat
software (version 3.1, obtained from Central Library of
Tabriz University of Medical Sciences, Tabriz, Iran). The
data were expressed as mean ± SEM and were analyzed
by one-way ANOVA in each experiment. In the case of
significant variation, the values were compared by
Tukey's test. Statistical significance was accepted at
the level of P < 0.05.
3 Results
3.1 Morphine WS in male and female rats
Figure 1 summarizes the number of withdrawal behaviors in male and female rats. As it has been shown,
the number of WDS, AW, and J in male rats was greater
than that in females (P < 0.001,
P < 0.05 and P < 0.01,
respectively). Male rats also showed more severe
naloxone-induced WS than females.
3.2 Effect of castration and flutamide on morphine WS
The results of morphine WS in 4-week castrated and
flutamide-treated (10 mg/kg/day for 8 days, i.p.) male
rats are shown in Figure 2. Castration caused a decrease
in the number of WDS, AW, and J behaviors in
comparison with male (non-castrated) and sham-operated rats
(P < 0.001 and P < 0.05, respectively). The number of
WDS, AW, and J was decreased (P < 0.05) by daily
injection of flutamide, as a testosterone receptor antagonist.
3.3 Effect of testosterone replacement therapy on
morphine WS
The effect of testosterone replacement therapy (10 mg/kg/day for 8 days, i.m.) on morphine WS was
investigated in 4-week castrated rats. As shown in Figure
3, the number of WDS, AW, and J increased to the male
rats level (P < 0.001 and
P < 0.05) by injection of
testosterone in castrated rats. Accordingly, we observed an
increase (P < 0.01) in WDS behavior in
testosterone-treated male rats in comparison with male (non-castrated)
rats.
4 Discussion
The results of this study establish that the
expression of physical dependence on morphine is more severe
in male rats than in females during naloxone-induced
withdrawal after chronic morphine treatment. It appears
that these differences might be associated with
gender-related distinctions in the sensitivity of the central
nervous system to the dependence-producing properties of
morphine, as it has been observed that pharmacokinetic
factors are the same in male and female rats [2]. Our
results are in agreement with the report showing that
males have more severe naloxone-induced WS than females [17]. In contrast, it has been reported that
naloxone-precipitated WS appears to be equivalent in most
aspects between male and female rats [18]. However, it
should be noted that this controversy could be due to
differences in doses, duration of treatment, and
withdrawal assay methods.
It has been reported that plasma concentration of
testosterone and dihydrotestosterone decreases markedly
4 weeks after castration of male rats [19_21]. Therefore,
we studied morphine WS in 4-week castrated rats as a
model of testosterone-depleted rats. According to our
present study, we observed that withdrawal behaviors in
male rats are significantly decreased by castration and
daily injection of flutamide (a testosterone receptor
antagonist). Thus, we might suggest a possible role for
testosterone in the behavioral responses to chronic
morphine treatment that appeared after naloxone injection.
Testosterone has also been found to modify endogenous
opioid peptides levels in various sites of brain [22].
Therefore, the roles of endogenous opioid peptides in
this regard should not be neglected.
In this study, we showed that the decrease in
morphine withdrawal behaviors in male castrated rats was
reversed by testosterone replacement therapy. Also,
testosterone injections in non-castrated male rats
potentiated the severity of behaviors. Recently it has been shown
that a higher testosterone level in male rats is one of the
most obvious reasons for the development of a clear
gender difference in locomotion activity [23], a further
indication of the possible role of male androgenic
hormone. Another study showed that castration reduces
aromatase activity in the hypothalamus_preoptic area of
adult rats [24]. As testosterone is converted to estradiol
by aromatase enzyme, so attention should be paid to the
possible role of estrogens in testosterone-related effects.
In conclusion, our data suggest that testosterone has an
effective role in severity of morphine withdrawal
behaviors. In addition, we suggest that investigation of a possible
clinical application of flutamide, as a testosterone
receptor antagonist, should be carried out to test its
usefulness in diminishing morphine dependency. Further
studies are needed to elucidate the exact mechanism of
testosterone on brain neuronal systems that are responsible to
development of dependency.
Acknowledgment
We wish to thank the Vice Chancellor's office for
Research Affairs of the Tabriz University of Medical
Sciences for the grant (No. 5-4-703) supporting this study.
References
1 Kepler KL, Kest B, Kiefel JM, Cooper ML, Bodnar RJ. Roles
of gender, gonadectomy and estrus phase in the analgesic
effects of intracerebroventricular morphine in rats. Pharmacol
Biochem Behav 1989; 34: 119_27.
2 Cicero TJ, Nock B, Meyer ER. Sex-related differences in
morphine's antinociceptive activity: relationship to serum and
brain morphine concentrations. Pharmacol Exp Ther 1997;
282: 939_44.
3 Kest B, Sarton E, Dahan A. Gender differences in
opioid-mediated analgesia. Anesthesiology 2000; 93: 539_49.
4 Craft RM. Sex differences in opioid analgesia: from mouse to
man. Clin J Pain 2003; 19: 175_86.
5 Holtman JR Jr, Sloan JW, Wala EP. Morphine tolerance in
male and female rats. Pharmacol Biochem Behav 2004; 77:
517_23.
6 Stewart J, Rodaros D. The effects of gonadal hormones on
the development and expression of the stimulant effects of
morphine in male and female rats. Behav Brain Res 1999;
102: 89_98.
7 Craft RM, Heideman LM, Bartok RE. Effect of gonadectomy
on discriminative stimulus effects of morphine in female
versus male rats. Drug Alcohol Depend 1999; 53: 95_109.
8 Cicero TJ, Nock B, Meyer ER. Gender-linked differences in
the expression of physical dependence in the rats. Pharmacol
Biochem Behav 2002; 72: 691_7.
9 Cicero TJ, Nock B, Meyer ER. Gender-related differences in
the antinociceptive properties of morphine. J Pharmacol Exp
Ther 1996; 279: 267_73.
10 Ruddy DS, Kulkarni SK. Chronic neurosteroid treatment
prevents the development of morphine tolerance and attenuates
abstinence behavior in mice. Eur J Pharmacol 1997; 337:
19_25.
11 Yan C, Hou Y. [Determination of neurosteroids in rat brain by
gas chromatography/mass spectrometry.] Se Pu 2004; 22:
12_15. (In Chinese).
12 Amini H, Ahmadiani A. In vivo evidence for increase in
5á-reductase activity in the rat central nervous system following
morphine exposure. Int J Dev Neurosci 2005; 975: 1_6.
13 Verdi J, Ahmadiani A. Finastride, 5á-reductase inhibitor,
potentiates antinociceptive effects of morphine, prevents the
development of morphine tolerance and attenuates abstinence
behavior in the rat. Horm Behav 2007; 51: 605_10.
14 Janik J, Callahan P, Rabii J. Morphine induced analgesia is
attenuated in post-partum lactating rats. Life Sci 1993; 52:
271_9.
15 Islam AK, Cooper ML, Bodnar RJ. Interactions among aging,
gender, and gonadectomy effects upon morphine
antinociception in rats. Physiol Behav 1993; 54: 45_53.
16 Nayebi AR, Rezazadeh H. Involvement of serotoninergic
mechanism in analgesia by castration and flutamide, a
testosterone antagonist, in the rat formalin test. Pharmacol Biochem
Behav 2004; 77: 9_14.
17 Craft RM, Stratmann JA, Bartok RE, Walpole TI, King SJ.
Sex differences in development of morphine tolerance and
dependence in the rat. Psychopharmacology 1999; 143: 1_7.
18 Ali BH, Sharif SI, Elkadi A. Sex differences and the effect of
gonadectomy on morphine-induced antinociception and
dependence in rats and mice. Clin Exp Pharmacol Physiol 1995;
22: 342_4.
19 Shen ZJ, Zhou XL, Lu YL, Chen ZD. Effect of androgen
deprivation on penile ultrastructure. Asian J Androl 2004; 5:
33_6.
20 Liu WJ, Xin ZC, Xin H, Yuan YM, Tian L, Guo YL. Effect of
icariin on erectile function and expression of nitric oxide
synthase isoforms in castrated rats. Asian J Androl 2005; 7:
381_8.
21 Shen ZJ, Chen SW, Lu YL, Li LY, Zhou XL, Zhang MG,
et al. Preliminary study on androgen dependence of calcitonin
gene-related peptide in rat penis. Asian J Androl 2005; 7: 55_9.
22 Gabriel SM, Simpkins JW, Kalra PS. Chronic morphine
treatment induces hypersensitivity to testosterone-negative feed
back in castrated male rats. Neuroendocrinology 1985; 40:
39_44.
23 Li JS, Huang YC. Early androgen treatment influences the
pattern and amount of locomotion activity differently and
sexually differentially in an animal model of ADHD. Behav
Brain Res 2006; 175: 176_82.
24 Roselli CE, Ellinwood WE, Resko JA. Regulation of brain
aromatase activity in rat. Endocrinology 1984; 114: 192_200.
|